News
Merck revealed promising Phase 3 trial results for WINREVAIR, a new treatment aimed at pulmonary arterial hypertension (PAH). The HYPERION study involved about 320 global participants already ...
The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...
The CDC’s Advisory Committee on Immunization Practices (ACIP) has blessed Merck’s new respiratory syncytial virus (RSV) shot ...
Jefferies analyst Akash Tewari remains bullish on Merck, maintaining a Buy rating and a $138 price target. The firm’s ...
Merck & Co., Inc. (NYSE:MRK) is another biopharmaceutical company on the list of the 10 undervalued blue chip stocks analysts ...
A draft agenda for an upcoming meeting of CDC vaccine experts indicated on Wednesday that there would be no discussion about ...
A few of the new members Health Secretary Robert F. Kennedy Jr. appointed to the federal panel have promoted misinformation ...
11d
Zacks Investment Research on MSNSlowing Gardasil Sales Hurt MRK's Top Line: Is Recovery in the Cards?Merck’s MRK second-largest product is Gardasil, which is a vaccine for the prevention of certain cancers caused by human ...
Merck & Co., Inc. (NYSE:MRK) is one of the 15 best stocks to invest in for an 18 year old. On June 10, Cantor Fitzgerald ...
U.S. Health and Human Services Secretary Robert F. Kennedy Jr., in an op-ed announcing the firing of all members of a federal advisory panel on vaccines, said he had gutted the group to restore the ...
Gardasil/Gardasil 9 sales declined 41% to $1.33 billion in the first quarter of 2025, primarily due to lower demand in China, partially offset by higher demand in most international regions ...
Please use one of the following formats to cite this article in your essay, paper or report: APA. Benchling. (2025, June 14). Benchling and Merck collaborate on vaccine bioanalysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results